Nothing Special   »   [go: up one dir, main page]

NO174394C - Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent - Google Patents

Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent

Info

Publication number
NO174394C
NO174394C NO890832A NO890832A NO174394C NO 174394 C NO174394 C NO 174394C NO 890832 A NO890832 A NO 890832A NO 890832 A NO890832 A NO 890832A NO 174394 C NO174394 C NO 174394C
Authority
NO
Norway
Prior art keywords
polymer
ion
carboxylic acid
preparation
acid group
Prior art date
Application number
NO890832A
Other languages
Norwegian (no)
Other versions
NO890832D0 (en
NO890832L (en
NO174394B (en
Inventor
Heribert Schmitt-Willich
Julius Deutsch
Heinz Gries
Jurgen Conrad
Reinhard Neumeier
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO890832D0 publication Critical patent/NO890832D0/en
Publication of NO890832L publication Critical patent/NO890832L/en
Publication of NO174394B publication Critical patent/NO174394B/en
Publication of NO174394C publication Critical patent/NO174394C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/146—Peptides, e.g. proteins the peptide being a polyamino acid, e.g. poly-lysine
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0206—Polyalkylene(poly)amines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0233—Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/12—Unsaturated polyimide precursors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

Polymers consisting of a ligand containing carboxylic acid groups and optionally of at least one ion of an element of atomic numbers 21- 29, 42, 44 or 57-83 and optionally cations of inorganic and/or organic bases, amino acids or amino acid amides are valuable complexing agents and complexes for diagnostics.
NO890832A 1988-02-29 1989-02-27 Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent NO174394C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3806795A DE3806795A1 (en) 1988-02-29 1988-02-29 POLYMER-TIED COMPLEX IMAGERS, THEIR COMPLEXES AND CONJUGATES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL AGENTS CONTAINING THEM

Publications (4)

Publication Number Publication Date
NO890832D0 NO890832D0 (en) 1989-02-27
NO890832L NO890832L (en) 1989-08-30
NO174394B NO174394B (en) 1994-01-17
NO174394C true NO174394C (en) 1994-04-27

Family

ID=6348654

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890832A NO174394C (en) 1988-02-29 1989-02-27 Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent

Country Status (6)

Country Link
EP (1) EP0331616B1 (en)
JP (1) JP2685568B2 (en)
AT (1) ATE130017T1 (en)
DE (2) DE3806795A1 (en)
GR (1) GR3018071T3 (en)
NO (1) NO174394C (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314681A (en) * 1988-12-23 1994-05-24 Nycomed Innovation Ab Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
US5364613A (en) * 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5230883A (en) * 1989-05-04 1993-07-27 Wisconsin Alumni Research Foundation Method for localization and treatment of tumors using polylysine complexes
DE3919915A1 (en) * 1989-06-19 1990-12-20 Boehringer Mannheim Gmbh AMINOALKYLMALEIMIDES AND DERIVED HAPTEN AND ANTIGEN DERIVATIVES AND CONJUGATES WITH PEPTIDES OR PROTEINS
US5972307A (en) * 1989-10-23 1999-10-26 Nycomed Salutar, Inc. Dichelants
GB9320277D0 (en) * 1993-10-01 1993-11-17 Nycomed Salutar Inc Chelants
US5650133A (en) * 1990-01-19 1997-07-22 Nycomed Salutar Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
DE3938992A1 (en) 1989-11-21 1991-05-23 Schering Ag Cascade polymer-bound complex formers, their complexes and conjugates, process for their preparation and pharmaceutical compositions containing them
WO1992017215A1 (en) 1990-03-28 1992-10-15 Nycomed Salutar, Inc. Contrast media
US5885549A (en) * 1991-02-01 1999-03-23 Imarx Pharmaceutical Corp. Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region
AU5085793A (en) * 1992-09-04 1994-03-29 General Hospital Corporation, The Biocompatible polymers containing diagnostic or therapeutic moieties
WO1994027498A1 (en) 1993-05-20 1994-12-08 The Regents Of The University Of California Macromolecular contrast media for mr imaging
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
WO1996010359A1 (en) * 1994-10-03 1996-04-11 The Trustees Of The University Of Pennsylvania Chelate complex with high conspicuity for magnetic resonance imaging
TW319763B (en) 1995-02-01 1997-11-11 Epix Medical Inc
DE19601060C2 (en) * 1996-01-04 2002-04-25 Schering Ag New monofunctionalized EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy
JP2001509796A (en) * 1997-01-29 2001-07-24 ニユコメド・イメージング・アクシエセルカペト Polymer
KR20000076368A (en) 1997-03-18 2000-12-26 아카이케 도시히로 Mri contrast media recognizing minor environmental changes
DE19728954C1 (en) * 1997-06-30 1999-04-22 Schering Ag Saccharide conjugates, pharmaceutical compositions containing them, processes for their preparation and their use
US6896874B2 (en) 1998-05-26 2005-05-24 Wisconsin Alumni Research Foundation MR-signal emitting coatings
US6361759B1 (en) 1998-05-26 2002-03-26 Wisconsin Alumni Research Foundation MR signal-emitting coatings
US6355224B1 (en) 1998-09-17 2002-03-12 Massachusetts Institute Of Technology Conductive polymer contrast agent compositions and uses therefor
US20040265235A1 (en) * 2003-06-26 2004-12-30 Uzgiris Egidijus Edward Magnetic resonance contrast-enhancing agents and method for detecting and imaging artherosclerotic plaque
US6960418B2 (en) * 2003-10-23 2005-11-01 Samsung Electronics Co., Ltd. Organophotoreceptor with charge transport material with two N,N,N-trisubstituted-amino groups
US7189879B2 (en) 2004-05-25 2007-03-13 Schering Ag Process for the production of 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride
DE102004026102B4 (en) * 2004-05-25 2006-08-24 Schering Ag Process for the preparation of 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride
DE102005056592A1 (en) * 2005-11-25 2007-05-31 Basf Ag Novel uncrosslinked, hyperbranched polylysines useful as e.g. adhesive aids, thixotropic agents or phase transfer agents are obtained by catalytic reaction of a salt of lysine with an acid and optionally with comonomers
US8457712B2 (en) 2005-12-30 2013-06-04 Wisconsin Alumni Research Foundation Multi-mode medical device system and methods of manufacturing and using same
US8532742B2 (en) 2006-11-15 2013-09-10 Wisconsin Alumni Research Foundation System and method for simultaneous 3DPR device tracking and imaging under MR-guidance for therapeutic endovascular interventions
DE102007002726A1 (en) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft New cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them
US8412306B2 (en) 2007-02-28 2013-04-02 Wisconsin Alumni Research Foundation Voltage standing wave suppression for MR-guided therapeutic interventions
DK2155254T3 (en) * 2007-05-09 2013-03-04 Nitto Denko Corp Polymer conjugated with platinum drugs
CN115304780B (en) * 2022-08-04 2023-06-13 上海师范大学 Preparation method and performance detection of metal-organic porous framework (MOFs) material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3129906C3 (en) * 1981-07-24 1996-12-19 Schering Ag Paramagnetic complex salts, their preparation and agents for use in NMR diagnostics
NL194579C (en) * 1983-01-21 2002-08-05 Schering Ag Diagnostic.
EP0268707A3 (en) * 1985-11-05 1989-03-08 The General Hospital Corporation Negatively charged specific affinity reagents
DE3701665A1 (en) * 1987-01-19 1988-07-28 Schering Ag POLYMER COMPLEXES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM

Also Published As

Publication number Publication date
EP0331616A3 (en) 1992-03-04
NO890832D0 (en) 1989-02-27
GR3018071T3 (en) 1996-02-29
NO890832L (en) 1989-08-30
ATE130017T1 (en) 1995-11-15
DE3806795A1 (en) 1989-09-07
DE58909479D1 (en) 1995-12-21
JP2685568B2 (en) 1997-12-03
NO174394B (en) 1994-01-17
EP0331616B1 (en) 1995-11-08
EP0331616A2 (en) 1989-09-06
JPH02196864A (en) 1990-08-03

Similar Documents

Publication Publication Date Title
NO174394C (en) Polymer complex consisting of at least one ion of an element of the order numbers 21-29, 42, 44 or 57-83 and a carboxylic acid group containing complexing polymer, preparation thereof, use thereof and diagnostic agent
DK0430863T4 (en) Cascade polymer complexes, their use and pharmaceutical agents containing them
ATE148121T1 (en) MESO-TETRAPHENYLPORPHYRINE COMPLEX COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING SAME
NO893245L (en) 13,17-PROPIONIC ACID AND PROPIONIC ACID DERIVATIVE-SUBSTITUTED PROFYRIN COMPLEX COMPOUNDS, AND DIAGNOSTIC AGENTS CONTAINING THESE.
ATE115546T1 (en) DERIVATIZED DTPA COMPLEXES, PHARMACEUTICAL AGENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE.
ATE124405T1 (en) 1,4,7,10-TETRAAZACYCLODODECAN BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING SAME.
DE69011230D1 (en) Radiation-resistant heat-sealable polymer mixtures and processes for their production.
PL303843A1 (en) Novel ligand compounds, method of obtaining them, complex compounds, method of diagnosing, pharmaceutical agent and diagnostic set
IE880127L (en) Polymercomplexes of metals
DE69017736D1 (en) Device for deciding the load state of a servo motor.